Dr Rosenberg on Efforts to Enhance Urothelial Cancer Treatment
Jonathan E. Rosenberg, MD, discusses ongoing and planned research efforts to enhance the frontline and beyond urothelial cancer treatment landscape.
Source: onclive.com
Jonathane Rosenberg News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jonathane Rosenberg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jonathane Rosenberg Today - Breaking & Trending Today
Dr Rosenberg on Toxicity Management With Enfortumab Vedotin Plus Pembrolizumab in Urothelial Cancer
Jonathan E. Rosenberg, MD, discusses toxicity management when administering enfortumab vedotin plus pembrolizumab in urothelial cancer.
Source: onclive.com
ADCs and Immunotherapy Broaden the Bladder Cancer Treatment Paradigm
Jonathan E. Rosenberg, MD, discusses how recent FDA approvals have revolutionized the treatment paradigm for locally advanced or metastatic bladder cancer.
Source: onclive.com
Enfortumab Vedotin Plus Pembrolizumab Has Potential to Alter SOC in Frontline Urothelial Cancer
The combination of enfortumab vedotin-ejfv plus pembrolizumab represents a chemotherapy-free regimen that could alter the standard of care in the frontline treatment of all patients with metastatic urothelial carcinoma.
Source: onclive.com
Tyra Biosciences Initiates SURF301 Phase 1/2 Clinical Study and Doses First Patient with TYRA-300
/PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance...
Source: prnewswire.com